Wall Street Analysts Believe Legend Biotech (LEGN) Could Rally 90.83%: Here's is How to Trade

Legend Biotech Corporation Sponsored ADR (LEGN) closed the last trading session at $43.95, gaining 0.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $83.87 indicates a 90.8% upside potential.The average comprises 19 short-term price targets ranging from a low of $60 to a high of $95, with a standard deviation of $9.51. While the lowest estimate indicates an increase of 36.5% fro ...